Enovis (ENOV) Cash from Investing Activities (2010 - 2026)

Enovis' (ENOV) quarterly Cash from Investing Activities came in at -$53.1 million in Q2 2026, up 12.27% year-on-year from -$47.3 million in Q2 2025, and down 308.71% on a QoQ basis from -$13.0 million in Q4 2025.

Enovis (ENOV) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Enovis (ENOV) has 17 years of Cash from Investing Activities data on file, last reported at -$53.1 million in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities rose 12.27% year-over-year to -$53.1 million in Q2 2026; TTM through Apr 2026 was -$171.9 million, a 21.18% increase from a year earlier, with the FY2025 full-year figure at -$179.4 million, up 81.23% from the prior year.
  • Cash from Investing Activities for Q2 2026 stood at -$53.1 million, down from -$13.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for ENOV reached as high as -$13.0 million in Q4 2025 and fell as low as -$797.8 million in Q1 2024.
  • Historically, Cash from Investing Activities has averaged -$94.5 million across 5 years, with a median of -$53.1 million in 2026.
  • Across the five-year window, Cash from Investing Activities tumbled 2220.32% in 2024 and jumped 92.41% in 2025, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$37.1 million in 2022, then slumped by 60.14% to -$59.4 million in 2023, then rose by 2.51% to -$57.9 million in 2024, then soared by 77.56% to -$13.0 million in 2025, then plunged by 308.71% to -$53.1 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$53.1 million in Q2 2026, -$13.0 million in Q4 2025, and -$56.1 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Enovis 1.61 Bn 1.58 Bn 365.49 Mn -53.10 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 -53.10 Mn
Apr 3, 2026 -53.10 Mn
Dec 31, 2025 -12.99 Mn
Dec 31, 2025 -12.99 Mn
Oct 3, 2025 -56.06 Mn
Oct 3, 2025 -56.06 Mn
Jul 4, 2025 -49.80 Mn
Jul 4, 2025 -49.80 Mn
Apr 4, 2025 -60.52 Mn
Apr 4, 2025 -60.52 Mn
Dec 31, 2024 -57.88 Mn
Dec 31, 2024 -57.88 Mn
Sep 27, 2024 -58.42 Mn
Sep 27, 2024 -58.42 Mn
Jun 28, 2024 -41.33 Mn
Jun 28, 2024 -41.33 Mn
Mar 29, 2024 -797.84 Mn
Mar 29, 2024 -797.84 Mn
Dec 31, 2023 -59.37 Mn
Dec 31, 2023 -59.37 Mn